New Valley Fever drug developed at University of Arizona shows promise; vaccine still ahead

Valley Fever drug advances

A drug developed at the University of Arizona's Valley Fever Center for Excellence appears to kill the fungus that causes Valley Fever, unlike traditional treatments that only stop its growth.

Key points Valley Fever drug advances
  1. A drug developed at the University of Arizona's Valley Fever Center for Excellence appears to kill the fungus that causes Valley Fever, unlike traditional treatments that only stop its growth.
  2. Researcher Dr. Fariba Donovan said patients on Olorofim alone are doing well, and the drug is in its second clinical trial with hopes of moving toward FDA review this year.
  3. Valley Fever is a non-contagious fungal infection spread by breathing dust in dry soil, and the Tucson-Phoenix corridor accounts for two-thirds of reported cases.
  4. A vaccine is close to approval for dogs, with human or primate trials possibly to follow.
Read the full story Valley Fever drug advances
Reported by

Arizona's Family

azfamily.com

© OpenStreetMap contributors

Maricopa County, AZ

Finding more…